Table 3 Details of PTC culture and drug screening
Variables | Success of PTC culture (n = 56) |
|---|---|
Culture duration (days) | 3.8 ± 2.3 |
Drug testing regimens | 9.3 ± 3.7 |
Cell-killing efficiency (%) | 42.7 ± 16.9 |
Strongest killing regimen | Â |
 Gemcitabine plus platinum | 24(42.9%) |
 Paclitaxel plus platinum | 8(14.3%) |
 Irinotecan plus platinum | 2(3.6%) |
 Paclitaxel plus gemcitabine | 2(3.6%) |
 Pemetrexed plus platinum | 3(5.4%) |
 Pirarubicin plus platinum | 3(5.4%) |
 Docetaxel plus platinum | 1(1.8%) |
 Osimertinib | 9(16.1%) |
 Anlotinib | 1(1.8%) |
 Gefitinib | 1(1.8%) |
 Icotinib | 1(1.8%) |
 Eptoside plus doxorubicin | 1(1.8%) |